BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24114045)

  • 1. Impaired sleep quality in Crohn's disease depends on disease activity.
    Gingold-Belfer R; Peled N; Levy S; Katz N; Niv Y; Fass R; Fraser G; Dickman R
    Dig Dis Sci; 2014 Jan; 59(1):146-51. PubMed ID: 24114045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery.
    Sofia MA; Lipowska AM; Zmeter N; Perez E; Kavitt R; Rubin DT
    Inflamm Bowel Dis; 2020 Jul; 26(8):1251-1259. PubMed ID: 31820780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients.
    Sobolewska-Włodarczyk A; Włodarczyk M; Talar M; Wiśniewska-Jarosińska M; Gąsiorowska A; Fichna J
    Pharmacol Rep; 2021 Dec; 73(6):1660-1669. PubMed ID: 34694623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported sleep disturbance in Crohn's disease is not confirmed by objective sleep measures.
    Iskandar HN; Linan EE; Patel A; Moore R; Lasanajak Y; Gyawali CP; Sayuk GS; Ciorba MA
    Sci Rep; 2020 Feb; 10(1):1980. PubMed ID: 32029832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
    Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm abnormalities in patients with inflammatory bowel disease - association with adipokine profile.
    Sobolewska-Włodarczyk A; Włodarczyk M; Zielińska A; Siwiński P; Wiśniewska-Jarosińska M; Gąsiorowska A; Fichna J
    Scand J Gastroenterol; 2020 Mar; 55(3):294-300. PubMed ID: 32180483
    [No Abstract]   [Full Text] [Related]  

  • 8. The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Qazi T; Verma R; Hamilton MJ; Kaplan ER; Redline S; Burakoff R
    Inflamm Bowel Dis; 2019 May; 25(6):1044-1053. PubMed ID: 30395256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between chronotype, sleep disturbances and seasonality with fatigue and inflammatory bowel disease symptoms.
    Chrobak AA; Nowakowski J; Zwolińska-Wcisło M; Cibor D; Przybylska-Feluś M; Ochyra K; Rzeźnik M; Dudek A; Arciszewska A; Siwek M; Dudek D
    Chronobiol Int; 2018 Aug; 35(8):1142-1152. PubMed ID: 29737879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbance and disease activity in adult patients with inflammatory bowel diseases.
    Sobolewska-Wlodarczyk A; Wlodarczyk M; Banasik J; Gasiorowska A; Wisniewska-Jarosinska M; Fichna J
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world.
    Pal P; Banerjee R; Vijayalaxmi P; Reddy DN; Tandan M
    Indian J Gastroenterol; 2024 Feb; 43(1):226-236. PubMed ID: 37851205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.
    Bar-Gil Shitrit A; Chen-Shuali C; Adar T; Koslowsky B; Shteingart S; Paz K; Grisaru-Granovsky S; Goldin E; Epstein Shochet G; Shitrit D
    Dig Dis Sci; 2018 Nov; 63(11):2992-2997. PubMed ID: 30027514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between disease activity index and sleep disorders in children with inflammatory bowel diseases.
    Gundogdu D; Urgancı N; Usta M
    Eur J Pediatr; 2023 Sep; 182(9):4095-4102. PubMed ID: 37405508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome.
    Lahiff C; Safaie P; Awais A; Akbari M; Gashin L; Sheth S; Lembo A; Leffler D; Moss AC; Cheifetz AS
    Aliment Pharmacol Ther; 2013 Apr; 37(8):786-94. PubMed ID: 23432394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients.
    Ali T; Madhoun MF; Orr WC; Rubin DT
    Inflamm Bowel Dis; 2013 Oct; 19(11):2440-3. PubMed ID: 23945186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study.
    Byrne MF; Farrell MA; Abass S; Fitzgerald A; Varghese JC; Thornton F; Murray FE; Lee MJ
    Clin Radiol; 2001 Dec; 56(12):973-8. PubMed ID: 11795926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Takahara I; Takeshima F; Ichikawa T; Matsuzaki T; Shibata H; Miuma S; Akazawa Y; Miyaaki H; Taura N; Nakao K
    Dig Dis Sci; 2017 Mar; 62(3):761-767. PubMed ID: 28035549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders.
    Salwen-Deremer JK; Smith MT; Haskell HG; Schreyer C; Siegel CA
    Dig Dis Sci; 2022 Jul; 67(7):3096-3107. PubMed ID: 34331174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study.
    Marinelli C; Savarino EV; Marsilio I; Lorenzon G; Gavaruzzi T; D'Incà R; Zingone F
    Sci Rep; 2020 Jan; 10(1):507. PubMed ID: 31949257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Colombel JF; Panaccione R; Bossuyt P; Lukas M; Baert F; Vaňásek T; Danalioglu A; Novacek G; Armuzzi A; Hébuterne X; Travis S; Danese S; Reinisch W; Sandborn WJ; Rutgeerts P; Hommes D; Schreiber S; Neimark E; Huang B; Zhou Q; Mendez P; Petersson J; Wallace K; Robinson AM; Thakkar RB; D'Haens G
    Lancet; 2017 Dec; 390(10114):2779-2789. PubMed ID: 29096949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.